It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

Eli Lilly and Co.’s recent decision to drop development at phase II of PD-1 agonist peresolimab in rheumatoid arthritis (RA) because of an inadequate benefit-risk profile brought further attention to ...

Some of the “anti-ageing” benefits seen with GLP1RAs may simply be the result of their weight-loss inducing properties.

Reduction in body weight can prevent, delay or reduce the development of these conditions with advancing age. GLP-1RAs, ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Wegovy and Ozempic are both brand-name semaglutide medications. The primary difference is the dosing and FDA approval. Wegovy ...

In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis ...